Immunology & Allergies

Immunology and allergy-related conditions affect the body's immune system, which can sometimes mistakenly attack healthy cells or overreact to harmless substances. Common conditions in this therapeutic area include asthma, eczema, food allergies, rheumatoid arthritis, and autoimmune diseases. These issues can significantly impact the quality of life, leading to chronic discomfort, inflammation, or even life-threatening reactions.

Current and upcoming medical research in immunology aims to deepen our understanding of the immune system's functions and malfunctions. Research focuses on developing targeted therapies, such as biologics, to modulate immune responses more precisely, reducing side effects and improving outcomes.

Today, treatments range from antihistamines and corticosteroids to immunotherapy and biologic drugs. However, clinical research plays a critical role in advancing these treatments, offering potential participants an opportunity to contribute to the discovery of new, more effective therapies that could improve their lives and the lives of millions affected by these conditions.

Momentum has conducted research in a wide range of immunology conditions including treatments for allergies, autoimmune disorders, respiratory conditions, and chronic inflammatory diseases. Research focusses on developing innovative therapies aimed at improving the quality of life for patients suffering from immune related conditions.

Recent research has included studies looking at: 

• Testing a treatment approved for multiple inflammatory conditions on adults with moderately to severely active Lupus. 
• Testing an investigational drug-free nasal spray which may prevent allergens from entering the nose.
• An investigational medication delivered via injection, for people with eosinophilic asthma, in which an increase in white blood cells causes inflammation of the airways leading to severe asthma attacks. 
• Investigational treatments for alopecia areata, an autoimmune disorder causing hair loss, which currently lacks approved systemic therapies for severe cases.
• Studying an investigational oral treatment, containing cannabidiol (CBD), that is intended to relieve pain and improve physical function in adults with rheumatoid arthritis.